Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$42.56 - $54.98 $29.8 Million - $38.5 Million
-700,000 Reduced 73.68%
250,000 $12.7 Million
Q1 2020

May 15, 2020

BUY
$32.37 - $59.36 $17.8 Million - $32.6 Million
550,000 Added 137.5%
950,000 $42.4 Million
Q3 2019

Nov 15, 2019

BUY
$33.82 - $48.17 $13.5 Million - $19.3 Million
400,000 New
400,000 $13.5 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.17B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.